Dupilumab treatment of nummular dermatitis: A retrospective cohort study

J Am Acad Dermatol. 2020 May;82(5):1252-1255. doi: 10.1016/j.jaad.2019.12.054. Epub 2020 Jan 8.

Authors

Sara Choi¹, Gefei A Zhu¹, Matthew A Lewis¹, Golara Honari¹, Albert S Chiou¹, Justin Ko¹, Jennifer K Chen²

Affiliations

¹ Department of Dermatology, Stanford University School of Medicine, Redwood City, California.
² Department of Dermatology, Stanford University School of Medicine, Redwood City, California. Electronic address: jenniferkchen@stanford.edu.

PMID: 31923445
DOI: 10.1016/j.jaad.2019.12.054

No abstract available

Publication types

Letter

MeSH terms

Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized / pharmacology
Antibodies, Monoclonal, Humanized / therapeutic use*
Eczema / blood
Eczema / drug therapy*
Eczema / immunology
Female
Humans
Lymphocyte Activation / drug effects
Male
Middle Aged
Retrospective Studies
Th2 Cells / drug effects
Th2 Cells / immunology
Treatment Outcome

Substances

Antibodies, Monoclonal, Humanized
dupilumab